We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

84 hedge funds and large institutions have $11M invested in Ampio Pharmaceuticals Inc. in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,814% more call options, than puts

Call options by funds: $204K | Put options by funds: $7K

52% more capital invested

Capital invested by funds: $7.24M → $11M (+$3.76M)

13% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 15

6% less funds holding

Funds holding: 89 → 84 (-5)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

Holders
84
Holders Change
-5
Holders Change %
-5.62%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
17
Reduced
15
Closed
10
Calls
$204K
Puts
$7K
Net Calls
+$197K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$332K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$316K
3
WS
Wedbush Securities
California
+$187K
4
Northern Trust
Northern Trust
Illinois
+$76.6K
5
RJA
Raymond James & Associates
Florida
+$62.9K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$109K
2
GCP
GSA Capital Partners
United Kingdom
-$60.6K
3
Citadel Advisors
Citadel Advisors
Florida
-$57.9K
4
UBS Group
UBS Group
Switzerland
-$44K
5
Group One Trading
Group One Trading
Illinois
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
51
Credit Suisse
Switzerland
$13K +$3.77K +22 +40%
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$12K – – –
OWP
53
Obermeyer Wealth Partners
Colorado
$11K – – –
VF
54
Virtu Financial
New York
$11K +$11.1K +65 New
TFS
55
TrustCore Financial Services
Tennessee
$10K – – –
JWM
56
Janiczek Wealth Management
Colorado
$9K – – –
GWM
57
Geneos Wealth Management
Colorado
$8K – – –
PNC Financial Services Group
58
PNC Financial Services Group
Pennsylvania
$8K – – –
AB
59
Amalgamated Bank
New York
$8K +$343 +2 +4%
BCM
60
Brookstone Capital Management
Illinois
$7K – – –
Legal & General Group
61
Legal & General Group
United Kingdom
$7K – – –
SG Americas Securities
62
SG Americas Securities
New York
$7K +$7.02K +41 New
RE
63
RBC Europe
United Kingdom
$6.37K – – –
OC
64
Oppenheimer & Co
New York
$6K – – –
ProShare Advisors
65
ProShare Advisors
Maryland
$6K +$171 +1 +3%
CAL
66
Capital Analysts LLC
Pennsylvania
$5K – – –
WA
67
WealthTrust Axiom
Pennsylvania
$5K – – –
Commonwealth Equity Services
68
Commonwealth Equity Services
Massachusetts
$5K +$5.82K +34 New
AIP
69
Ameritas Investment Partners
Nebraska
$4K – – –
Northwestern Mutual Wealth Management
70
Northwestern Mutual Wealth Management
Wisconsin
$4K – – –
TRCT
71
Tower Research Capital (TRC)
New York
$3K -$4.28K -25 -57%
LTFS
72
Ladenburg Thalmann Financial Services
Florida
$3K – – –
Bank of America
73
Bank of America
North Carolina
$2K -$22.3K -130 -92%
CCM
74
Covington Capital Management
California
$2K – – –
RFM
75
Royal Fund Management
Florida
$2K – – –
1 2
3
4

AMPE Hedge Fund Activity: Q1 2019 in Review

84 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2019, worth a combined $11M — up 52% from $7.24M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AMPE and 5 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 17 added.

The largest buyer was BlackRock, adding an estimated $332K. The largest seller was Morgan Stanley, cutting an estimated $109K.

  • 84 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2019, down from 89 in Q4 2018.
  • Funds reported $11M of Ampio Pharmaceuticals Inc. stock for Q1 2019, up 52% quarter-over-quarter.
  • 5 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2019 and 10 closed out, a net change of -5 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2019 was BlackRock, an estimated $332K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2019 was Morgan Stanley, an estimated $109K sold.

Based on aggregated 13F filings for Q1 2019.